SAB Biotherapeutics(SABS)
$2.96-0.12 (-3.90%)
SABS
SAB Biotherapeutics similar stocks
$2.96
At close:-0.12 (-3.90%)
Want to see SABS full AI Analyst Report?
Compare SAB Biotherapeutics (SABS) vs. Competitors
332 Followers
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| SABSSAB Biotherapeutics | $2.96 | $266.66M | -3.18 | -4.52% | Strong Buy | Unlock the SABS analyst price target with TipRanks Premium | SABS | Unlock the SABS top-analyst price target with TipRanks Premium | ||
| LSTALisata Therapeutics | $1.21 | $13.07M | -0.64 | -41.55% | ― | Unlock the LSTA analyst price target with TipRanks Premium | SABS vs LSTA | Unlock the LSTA top-analyst price target with TipRanks Premium | ||
| NXTCNextCure | $6.40 | $29.31M | -0.74 | -34.43% | ― | Unlock the NXTC analyst price target with TipRanks Premium | SABS vs NXTC | Unlock the NXTC top-analyst price target with TipRanks Premium | ||
| RLYBRallybio | $15.72 | $84.64M | 3.41 | 199.54% | ― | Unlock the RLYB analyst price target with TipRanks Premium | SABS vs RLYB | Unlock the RLYB top-analyst price target with TipRanks Premium |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| SABS | SAB Biotherapeutics | 2.96 | -0.54 | -15.43% | |
| LSTA | Lisata Therapeutics | 1.21 | -0.88 | -42.11% | |
| NXTC | NextCure | 6.40 | -3.74 | -36.88% | |
| RLYB | Rallybio | 15.72 | 10.78 | 218.48% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

